These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Malondialdehyde formation as an indicator of prostaglandin production by human platelets. Smith JB; Ingerman CM; Silver MJ J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533 [TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans. Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529 [No Abstract] [Full Text] [Related]
6. The influence of aspirin and indomethacin on the platelet contractile wave. Gerrard JM; White JG Am J Pathol; 1976 Mar; 82(3):513-26. PubMed ID: 1258974 [TBL] [Abstract][Full Text] [Related]
7. Arachidonic acid-induced human platelet aggregation and prostaglandin formation. Silver MJ; Smith JB; Ingerman C; Kocsis JJ Prostaglandins; 1973 Dec; 4(6):863-75. PubMed ID: 4205973 [No Abstract] [Full Text] [Related]
8. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin. Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511 [TBL] [Abstract][Full Text] [Related]
9. Collagen-induced platelet aggregation: evidence of several mechanisms for the induction of platelet release by collagen. Nyman D Thromb Res; 1977 May; 10(5):743-51. PubMed ID: 882960 [No Abstract] [Full Text] [Related]
10. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro. Johnstone IB Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184 [TBL] [Abstract][Full Text] [Related]
11. Formation of prostagland in D2 during endoperoxide-induced platelet aggregation. Smith JB; Ingerman CM; Silver MJ Thromb Res; 1976 Oct; 9(4):413-8. PubMed ID: 982358 [No Abstract] [Full Text] [Related]
12. The effect of ibuprofen dose on rabbit platelet aggregation and aortic pgi2 synthesis. Adesuyi SA; Ellis EF Thromb Res; 1982 Nov; 28(4):581-5. PubMed ID: 6761894 [No Abstract] [Full Text] [Related]
13. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent. De Caterina R; Giannessi D; Gazzetti P; Bernini W Thromb Res; 1985 Jan; 37(2):337-42. PubMed ID: 3975876 [No Abstract] [Full Text] [Related]
14. In vitro evaluation of inhibitors of platelet release and aggregation. Rosenberg JC; Sell TL Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838 [TBL] [Abstract][Full Text] [Related]
15. Effects of aspirin on platelet aggregation as a function of dosage and time. Paccioretti MJ; Block LH Clin Pharmacol Ther; 1980 Jun; 27(6):803-9. PubMed ID: 7379449 [TBL] [Abstract][Full Text] [Related]
16. Effect of nabumetone (BRL 14777), a new anti-inflammatory drug, on human platelet reactivity ex vivo: comparison with naproxen. Nunn B; Chamberlain PD J Pharm Pharmacol; 1982 Sep; 34(9):576-9. PubMed ID: 6127382 [TBL] [Abstract][Full Text] [Related]
17. Roles of cyclic nucleotides in platelet function. Haslam RJ Ciba Found Symp; 1975; 35():121-51. PubMed ID: 179765 [No Abstract] [Full Text] [Related]
18. Butyltin compounds in vitro inhibition of human platelet epinephrine-induced aggregation and blockade of epinephrine binding to platelets. Yanagisawa H; Wada O Ind Health; 1985; 23(4):255-68. PubMed ID: 3938784 [No Abstract] [Full Text] [Related]
20. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation. Huzoor-Akbar ; Anwer K Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]